Stay updated on Nintedanib IPF Trial: Twice Daily vs Placebo
Sign up to get notified when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.

Latest updates to the Nintedanib IPF Trial: Twice Daily vs Placebo page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedPublications text updated to clarify auto-fill from PubMed; revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedThe notice about government funding and operating status was removed from the page; this does not affect the study content or results, and core trial information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check49 days agoChange DetectedNo significant changes were detected between the two screenshots. The study details and sections remain the same, with only minor UI/formatting differences if any.SummaryDifference0.3%

- Check70 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference3%

- Check77 days agoChange DetectedThe page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page updates from v3.0.1 to v3.0.2 contain no substantive content changes; only a non-critical element ('Back to Top') was removed. Overall, core content and important details appear unchanged.SummaryDifference0.2%

Stay in the know with updates to Nintedanib IPF Trial: Twice Daily vs Placebo
Enter your email address, and we'll notify you when there's something new on the Nintedanib IPF Trial: Twice Daily vs Placebo page.